Insights into the connection between cancer and alternative splicing.

Computational and experimental evidence has revealed that cancerous cells express transcript variants that are abnormally spliced, suggesting that mRNAs are more frequently alternatively spliced in cancerous tissues than in normal ones. We show that cancerous tissues exhibit lower levels of alternative splicing than do normal tissues. Moreover, we found that the distribution of types of alternative splicing differs between cancerous and normal tissues. We further show evidence suggesting that the lower levels of alternative splicing in cancerous tissues might be a result of disruption of splicing regulatory proteins.

[1]  T. Cooper,et al.  Pre-mRNA splicing and human disease. , 2003, Genes & development.

[2]  J. Venables.  Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[3]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[4]  B. Graveley.  Alternative splicing: increasing diversity in the proteomic world. , 2001, Trends in genetics : TIG.

[5]  M. Garcia-Blanco,et al.  Alternative splicing in disease and therapy , 2004, Nature Biotechnology.

[6]  G. Ast,et al.  Different levels of alternative splicing among eukaryotes , 2006, Nucleic acids research.

[7]  Ryan D. Morin,et al.  The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). , 2004, Genome research.

[8]  A. Krainer,et al.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.

[9]  G. Riggins,et al.  Splicing factors are differentially expressed in tumors. , 2004, Genetics and molecular research : GMR.

[10]  J. Figge,et al.  Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  David Haussler,et al.  Transcriptome and Genome Conservation of Alternative Splicing Events in Humans and Mice , 2003, Pacific Symposium on Biocomputing.

[12]  C. V. Jongeneel,et al.  eVOC: a controlled vocabulary for unifying gene expression data. , 2003, Genome research.

[13]  K. Buetow,et al.  Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. , 2003, Cancer research.

[14]  Tyson A. Clark,et al.  Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. , 2007, Genes & development.

[15]  Yixue Li,et al.  Identification of alternatively spliced mRNA variants related to cancers by genome-wide ESTs alignment , 2004, Oncogene.

[16]  Gil Ast,et al.  How did alternative splicing evolve? , 2004, Nature Reviews Genetics.

[17]  Christopher J. Lee,et al.  A genomic view of alternative splicing , 2002, Nature Genetics.

[18]  S. Berget.  Exon Recognition in Vertebrate Splicing (*) , 1995, The Journal of Biological Chemistry.

[19]  L. Tartaglia,et al.  A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.

[20]  Daniel L. Hartl,et al.  GeneMerge - Post-genomic Analysis, Data Mining, and Hypothesis Testing , 2003, Bioinform..

[21]  B. Blencowe.  Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. , 2000, Trends in biochemical sciences.

[22]  W. Symmans,et al.  Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. , 2003, Cancer research.

[23]  F. Amalric,et al.  THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies , 2003, Oncogene.

[24]  S. Brenner,et al.  Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements , 2007, Nature.

[25]  J. Kawai,et al.  Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas , 2004, Nature Methods.

[26]  Christopher J. Lee,et al.  Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms , 2005, Nucleic acids research.

[27]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[28]  Wei Zhang,et al.  Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas. , 2005, Cancer research.

[29]  S. Nagata,et al.  A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.

[30]  V. Beneš,et al.  Alternative Splicing Microarrays Reveal Functional Expression of Neuron-specific Regulators in Hodgkin Lymphoma Cells* , 2005, Journal of Biological Chemistry.

[31]  G. Rubin,et al.  A computer program for aligning a cDNA sequence with a genomic DNA sequence. , 1998, Genome research.

[32]  A. Ullrich,et al.  The secreted tumor-associated antigen 90K is a potent immune stimulator. , 1994, The Journal of biological chemistry.

[33]  Christopher J. Lee,et al.  Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. , 2003, Nucleic acids research.

[34]  B. Blencowe.  Alternative Splicing: New Insights from Global Analyses , 2006, Cell.